Clinical Trial Update: The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing ZR2 to R-miniCHOP in unfit or frail de novo diffuse large B-cell lymphoma patients aged 70 or older; status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• R-miniCHOP (undefined)
• ZR2

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B-Cell Lymphoma | Phase 3 | Status: UNKNOWN